EPIX ESSA Pharma
- 5.700
- -0.550-8.80%
- 5.980
- +0.280+4.91%
ESSA Pharma News
Essa Pharma Is Maintained at Outperform by Oppenheimer
Essa Pharma Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on ESSA Pharma, Maintains $17 Price Target
Oppenheimer analyst Leland Gershell maintains ESSA Pharma with a Outperform and maintains $17 price target.
ESSA Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 172.44% Oppenheimer $17 → $17 Maintains Outperform 12/13/2023 172.44% Oppenheimer → $17 Reitera
Oppenheimer Sticks to Its Buy Rating for ESSA Pharma (EPIX)
Buy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion Potential
ESSA Pharma (EPIX.US): The 2024 Q2 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -0.20 dollars, previous value of -0.16 dollars, expected value of -0.19 dollars.
ESSA Pharma (EPIX.US): The 2024 Q2 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -0.20 dollars, previous value of -0.16 dollars, expected value of -0.19 dollars.
ESSA Pharma's Promising Prostate Cancer Trial Updates
ESSA Pharma | 10-Q: Quarterly report
Essa Pharma 2Q Research and Development Expenditures $6.2M >EPIX
Essa Pharma 2Q Research and Development Expenditures $6.2M >EPIX
Press Release: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024 Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, Canada, May 14, 2024 Co
Essa Pharma 2Q Loss/Shr 20c >EPIX
Essa Pharma 2Q Loss/Shr 20c >EPIX
ESSA Pharma(EPIX.US) Officer Sells US$4,823.3 in Common Stock
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 694 shares of common stock on May 6, 2024 at an average price of $6.95 for a total value of $4,823.3.Source: Announcement What is statement of changes
We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, ESSA Pharma (NASDAQ:EPIX) shareholders have done very
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
ESSA Pharma(EPIX.US) Officer Sells US$5,510.36 in Common Stock
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 694 shares of Common Stock on Apr 5, 2024 at an average price of $7.94 for a total value of $5,510.36.Source: Announcement What is statement of changes
ESSA Pharma Shareholders Show Strong Support
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing
ESSA Pharma(EPIX.US) Officer Sells US$6,232.12 in Common Stocks
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 694 shares of Common Stocks on Mar 5, 2024 at an average price of $8.98 for a total value of $6,232.12.Source: Announcement What is statement of change
12 $10 Stocks That Will Triple
Analysis
Price Target
No Data
